PMON49 Checkpoint Inhibitor Induced Hypophysitis with Growth Hormone Deficiency and Implications for the Treatment of ACTH Deficiency

BACKGROUND/PURPOSE: Hypophysitis is a known complication of immune checkpoint inhibitor (ICI) therapies used in the treatment of malignant cancers. In general, central adrenal insufficiency (AI) and hypothyroidism are the most recognized deficiencies following a diagnosis of ICI induced hypophysitis...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCherney, Stephen, Favoreto, Natalia, Fiacco, Nicholas, Ishizawar, Rumey, Saxena-Beem, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625555/
http://dx.doi.org/10.1210/jendso/bvac150.1151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625555/
http://dx.doi.org/10.1210/jendso/bvac150.1151

Ejemplares similares